Skip to main content
Clinical Trials/NCT04739488
NCT04739488
Completed
Not Applicable

The Effects of Breathing Exercises and Inhaler Training for Chronic Obstructive Pulmonary Disease Patients on the Severity of Dyspnea and Life Quality

Kirsehir Ahi Evran Universitesi1 site in 1 country67 target enrollmentSeptember 10, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Kirsehir Ahi Evran Universitesi
Enrollment
67
Locations
1
Primary Endpoint
COPD assessment test (CAT)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The most common symptom of chronic obstructive pulmonary disease (COPD) is shortness of breath and causes a decrease in the patient's quality of life. The best way to relieve shortness of breath is inhaler therapy. However, it is known that patients frequently apply this treatment incorrectly. The aim of this study is to determine the effects of breathing exercises and inhaler training for COPD patients on the severity of dyspnea and life quality.

For this, two patient groups with a total of 67 people were included in the study. While one group was trained on inhaler drug use, the other group was taught breathing exercises in addition to the inhaler drug use training. Patients were asked to continue the practices they learned regularly for 4 weeks. At the end of the study, it was observed that shortness of breath decreased and the quality of life increased in both patient groups.

Registry
clinicaltrials.gov
Start Date
September 10, 2017
End Date
December 25, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kirsehir Ahi Evran Universitesi
Responsible Party
Principal Investigator
Principal Investigator

Yasemin CEYHAN

Assistant Professor Yasemin CEYHAN

Kirsehir Ahi Evran Universitesi

Eligibility Criteria

Inclusion Criteria

  • The individuals over the age of 18,
  • Who had been diagnosed with COPD for at least three months,
  • Using inhalers at least twice a day,
  • Misusing their drug,
  • Had not previously taken breathing exercise training
  • Had not participated in a rehabilitation program

Exclusion Criteria

  • Mental disorders,
  • Communication disabilities,
  • Heart disease that could lead to dyspnea,
  • Unstable angina

Outcomes

Primary Outcomes

COPD assessment test (CAT)

Time Frame: It was administered to patients in both groups when they were first enrolled in the study.

The scale developed by Jones et al. (2009) is used to measure the health status of individuals with COPD.

St. George's respiratory questionnaire (SGRQ)

Time Frame: It was administered to patients in both groups when they were first enrolled in the study.

It is a quality of life questionnaire specific to patients with COPD developed by Jones and Forde (2008).

Patient Information Form

Time Frame: It was administered to patients in both groups when they were first included in the study.

Consisted of 19 questions including sociodemographic and disease features of the patients

Breathing Exercise and Inhaler Application Skill Chart

Time Frame: It was administered to patients in breathing ezercises and inhaler training group when they were first enrolled in the study.

Consisted of 18 items including the steps of breathing exercises and inhaler utilization to be applied to breathing exercises and inhaler group.

Inhaler Application Skill Chart

Time Frame: It was administered to patients in inhaler training group when they were first enrolled in the study.

Consisted of 10 items including only the skill of applying inhaler to be applied to the both group. Correct steps were evaluated as 1 point and wrong steps as 0 points. It was administered to patients when they were first enrolled in the study and when they came for control four weeks later.

Modified medical research council (mMRC)

Time Frame: It was administered to patients in both groups when they were first enrolled in the study.

It was developed by the British Medical Research Council in order to provide information about the degree of dyspnea experienced by the patient based on the patient's activity and the patient's perception of the disease. As it is a one-dimensional scale Cronbach's α coefficient could not be calculated.

Secondary Outcomes

  • Modified medical research council (mMRC)(It was administered to patients in both groups when they came for control four weeks later.)
  • COPD assessment test (CAT)(It was administered to patients in both groups when they came for control four weeks later.)
  • Inhaler Application Skill Chart(It was administered to patients in inhaler training group when they came for control four weeks later.)
  • Breathing Exercise and Inhaler Application Skill Chart(It was administered to patients in breathing ezercises and inhaler training group when they came for control four weeks later.)
  • St. George's respiratory questionnaire (SGRQ)(It was administered to patients in both groups when they came for control four weeks later.)

Study Sites (1)

Loading locations...

Similar Trials